Amylin Pharmaceuticals Has an Alliance with Eli Lilly & Co

Multiple Choice

Amylin Pharmaceuticals has an alliance with Eli Lilly & Co. to produce diabetes drugs. Lilly, however, recently signed an alliance agreement with another company to also produce diabetes drugs. As a result, Amylin sued Lilly for breech of the alliance agreement. Which of the following risks of cooperative strategies discussed in the chapter is most likely occurring here?

A) Having a true perception of the partner's trustworthiness.
B) Failing to make available to its partners the resources and capabilities that it committed to the cooperative strategy.
C) The partner misrepresenting competencies it can bring to the partnership.
D) Opportunistic behavior.